Immunomodulatory effects of quinolones.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Lancet. Infectious Diseases (Print)

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1473-3099(03)00658-3PMID 12781508
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Quinolones on Intestinal Ecology

  2012cited by this paper
• Quinolones and Eukaryotic Topoisomerases

  2003cited by this paper
• Modulation of Release of Proinflammatory Bacterial Compounds by Antibacterials: Potential Impact on Course of Inflammation and Outcome in Sepsis and Meningitis

  2002cited by this paper
• Lack of Interaction of Fluoroquinolones with Lipopolysaccharides

  2002cited by this paper
• Fluoroquinolone resistance among Gram-positive cocci.

  2002cited by this paper
• Effect of ciprofloxacin on lethal and sublethal challenge with endotoxin and on early cytokine responses in a murine in vivo model.

  2002cited by this paper
• Priming by grepafloxacin on respiratory burst of human neutrophils: its possible mechanism.

  2002cited by this paper
• Activity of Quinolones Against Gram-Positive Cocci: Mechanisms of Drug Action and Bacterial Resistance

  2002cited by this paper
• Immunomodulatory and Protective Effects of Moxifloxacin against Candida albicans-Induced Bronchopneumonia in Mice Injected with Cyclophosphamide

  2002cited by this paper
• Missing pieces in the NF-kappaB puzzle.

  2002cited by this paper
• Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide.

  2002cited by this paper
• Comparative Intracellular (THP-1 Macrophage) and Extracellular Activities of β-Lactams, Azithromycin, Gentamicin, and Fluoroquinolones against Listeria monocytogenes at Clinically Relevant Concentrations

  2002cited by this paper
• Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance

  2002cited by this paper
• Immunomodulating Activity of Quinolones: Review

  2002cited by this paper
• Atherosclerosis and Cancer

  2001cited by this paper
• Uptake, Transport, and Delivery of Antimicrobial Agents by Human Polymorphonuclear Neutrophils

  2001cited by this paper
• Different Subsets of Enteric Bacteria Induce and Perpetuate Experimental Colitis in Rats and Mice

  2001cited by this paper
• Immunomodulatory effects of moxifloxacin in comparison to ciprofloxacin and G‐CSF in a murine model of cyclophosphamide‐induced leukopenia †

  2001cited by this paper
• Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde.

  2001cited by this paper
• Gram-Positive and Gram-Negative Bacteria Do Not Trigger Monocytic Cytokine Production through Similar Intracellular Pathways

  2001cited by this paper
• Immunomodulation by Macrolide Antibiotics

  2001cited by this paper
• Atherosclerosis and cancer: common molecular pathways of disease development and progression.

  2001cited by this paper
• The effect of three broad-spectrum antimicrobials on mononuclear cell responses to encapsulated bacteria: evidence for down-regulation of cytokine mRNA transcription by trovafloxacin.

  2000cited by this paper
• Influence of Levofloxacin on Cytokine Production in Human Tonsillar Lymphocytes.

  2000cited by this paper
• Interference of Antibacterial Agents with Phagocyte Functions: Immunomodulation or “Immuno-Fairy Tales”?

  2000cited by this paper
• Protection against Lipopolysaccharide-Induced Death by Fluoroquinolones

  2000cited by this paper
• Comparative in vitro activity of gemifloxacin.

  2000cited by this paper
• Effects of trovafloxacin on the IL-1-dependent activation of E-selectin in human endothelial cells in vitro.

  2000cited by this paper
• Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes.

  2000cited by this paper
• Effect of grepafloxacin on cytokine production in vitro.

  2000cited by this paper
• Effect of ciprofloxacin on the activation of the transcription factors nuclear factor kappaB, activator protein-1 and nuclear factor-interleukin-6, and interleukin-6 and interleukin-8 mRNA expression in a human endothelial cell line.

  2000cited by this paper
• Ciprofloxacin Affects Pregnancy Loss in CBA/JxDBA/2J Mice Possibly via Elevation of Interleukin‐3 and Granulocyte Macrophage‐Colony Stimulating Factor Production

  2000cited by this paper
• Immunity and probiotics.

  1999cited by this paper
• Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae.

  1999cited by this paper
• Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis.

  1999cited by this paper
• A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.

  1999cited by this paper
• New horizons in the treatment of irritable bowel syndrome.

  1999cited by this paper
• CROHN'S DISEASE IN CHILDREN AND ADOLESCENTS : WHAT ARE THE TREATMENT OPTIONS?

  1999cited by this paper
• Probiotics and the immune system.

  1999cited by this paper
• Grepafloxacin inhibits tumor necrosis factor-alpha-induced interleukin-8 expression in human airway epithelial cells.

  1999cited by this paper
• Medical therapy of inflammatory bowel disease.

  1999cited by this paper
• Probiotics A critical review

  1999cited by this paper
• Comparative studies of modulatory effect to the function of rat peritoneal neutrophils treated with new quinolones.

  1999cited by this paper
• Possible interaction between new quinolones and immune functions in macrophages.

  1999cited by this paper
• Intrapulmonary concentrations of antimicrobial agents.

  1998cited by this paper
• Give us this day our daily germs.

  1998cited by this paper
• Give us this day our daily germs.

  1998cited by this paper
• Ciprofloxacin Inhibits Activation of Latent Human Immunodeficiency Virus Type 1 in Chronically Infected Promonocytic U1 Cells

  1998cited by this paper
• Effect of Trovafloxacin on Production of Cytokines by Human Monocytes

  1998cited by this paper
• Ciprofloxacin Induces an Immunomodulatory Stress Response in Human T Lymphocytes

  1998cited by this paper
• Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils.

  1998cited by this paper
• Interleukin-3 and pregnancy loss in antiphospholipid syndrome.

  1998cited by this paper
• Anti-phospholipid syndrome: from patient's bedside to experimental animal models and back to the patient's bedside.

  1998cited by this paper
• Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression.

  1998cited by this paper
• Toxicology and Safety Pharmacology of Quinolones

  1998cited by this paper
• Pharmacokinetics of selected antibacterial agents.

  1997cited by this paper
• Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones

  1997cited by this paper
• In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli

  1997cited by this paper
• Modulation of the Production of Cytokines in Titanium-Stimulated Human Peripheral Blood Monocytes by Pharmacological Agents. The Role of cAMP-Mediated Signaling Mechanisms*†

  1997cited by this paper
• Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice

  1997cited by this paper
• Effect of ciprofloxacin on the accumulation of interleukin-6, interleukin-8, and nitrite from a human endothelial cell model of sepsis.

  1997cited by this paper
• The effect of antimicrobial agents on the induction of tumour necrosis factor by alveolar macrophages in vitro in response to endotoxin.

  1997cited by this paper
• Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1

  1996cited by this paper
• Stimulation by Parathyroid Hormone of Interleukin-6 and Leukemia Inhibitory Factor Expression in Osteoblasts Is an Immediate-early Gene Response Induced by cAMP Signal Transduction (*)

  1996cited by this paper
• Impact of different classes antimicrobial agents on plasma endotoxin activity.

  1996cited by this paper
• Fleroxacin enhancement of superoxide production by polymorphonuclear leukocytes: the role of protein kinases.

  1996cited by this paper
• Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells.

  1996cited by this paper
• [Seminal plasma cytokines in nonbacterial prostatitis: changes following sparfloxacin treatment].

  1995cited by this paper
• Effect of ciprofloxacin on hematologic parameters in breast cancer patients receiving chemotherapy

  1995cited by this paper
• Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole.

  1995cited by this paper
• Monthly Update: Anti-Infectives the Immunomodulatory Activities of Antibacterials

  1995cited by this paper
• Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial.

  1995cited by this paper
• Superinduction of cytokine gene transcription by ciprofloxacin.

  1994cited by this paper
• Evidence that the antibiotic ciprofloxacin counteracts cyclosporine-dependent suppression of cytokine production.

  1994cited by this paper
• Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

  1994cited by this paper
• Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin.

  1994cited by this paper
• Medical therapy for inflammatory bowel disease.

  1994cited by this paper
• Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

  1994cited by this paper
• Ciprofloxacin enhances hematopoiesis and the peritoneal neutrophil function in lethally irradiated, bone marrow-transplanted mice.

  1994cited by this paper
• Effect of rufloxacin upon non-specific immune defences: in-vitro, ex-vivo and in-vivo results.

  1994cited by this paper
• Recombinant GM-CSF reduces lung injury and mortality during neutropenic Candida sepsis.

  1994cited by this paper
• In vivo effects of rufloxacin and ciprofloxacin on T-cell subsets and tumor necrosis factor production in mice infected with Bacteroides fragilis

  1993cited by this paper
• [Immunomodulating effects of antibiotics influencing digestive flora].

  1993cited by this paper
• Enhancement of superoxide production of polymorphonuclear neutrophils by ofloxacin and the effects of the inhibitors of protein kinase C.

  1993cited by this paper
• Quinolone antimicrobial agents

  1993cited by this paper
• Effect of short‐term therapy with ciprofloxacin, ceftriaxone and placebo on human peripheral WBC and marrow‐derived granulocyte‐macrophage progenitor cells (CFU‐GM)

  1992cited by this paper
• Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity.

  1992cited by this paper
• Effect of rufloxacin on in-vitro proliferation and differentiation of human mononuclear cells.

  1992cited by this paper
• Evaluation of temafloxacin in a rat model of intra-abdominal abscess.

  1992cited by this paper
• Immunomodulating effects of antibiotics.

  1992cited by this paper
• Protective effects of ciprofloxacin against type II collagen induced arthritis in rats.

  1992cited by this paper
• Cytotoxicity of quinolones toward eukaryotic cells. Identification of topoisomerase II as the primary cellular target for the quinolone CP-115,953 in yeast.

  1992cited by this paper
• Ciprofloxacin enhances T cell function by modulating interleukin activities

  1991cited by this paper
• Ciprofloxacin treatment in vivo increases the ex vivo capacity of lipopolysaccharide‐stimulated human monocytes to produce IL‐1, IL‐6 and tumour necrosis factor‐alpha

  1991cited by this paper
• Enhanced repopulation of murine hematopoietic organs in sublethally irradiated mice after treatment with ciprofloxacin.

  1991cited by this paper
• Immunological aspects of new quinolones

  1991cited by this paper
• Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon.

  1991cited by this paper
• Intracellular distribution and activity of antibiotics

  1991cited by this paper
• Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2]

  1990cited by this paper
• Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages.

  1990cited by this paper

• Early post-hatching effects of antibiotics and ionophore coccidiostat supplementation on immune parameters in turkeys

  2025cites this paper
• Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management

  2025cites this paper
• Inhaled liposomal ciprofloxacin protects against lethal tularemia in the common marmoset

  2025cites this paper
• Suppressive effect of topical moxifloxacin on imiquimod-induced model of psoriasis in mice

  2025cites this paper
• The most recent updates on the anticancer potential of fluoroquinolones: a mini review.

  2025cites this paper
• The double-edged sword: impact of antibiotic use on immunotherapy efficacy in advanced hepatocellular carcinoma

  2025cites this paper
• Pharmacological evaluation of levofloxacin residue depletion and hemato-biochemical alterations in broiler chickens using a validated HPLC method

  2025cites this paper
• Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck

  2025cites this paper
• Comprehensive in-vitro antibacterial and in-silico anti-viral evaluations of selected fluorinated-quinolone ligands and their Ag/Zn-based coordination polymers

  2025cites this paper
• Development of a System to Deliver Inhalational Antibiotics to Marmosets

  2025cites this paper
• Epac (RAPGEF3) promotes betaglycan expression to mediate ciprofloxacin-induced suppression of cancer cell migration and metastasis: Mechanistic insights and drug repurposing potential.

  2025cites this paper
• Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway

  2025cites this paper
• Single and mixture exposure to atrazine and ciprofloxacin on Clarias gariepinus antioxidant defense status, hepatic condition and immune response.

  2024cites this paper
• Differences in nature killer cell response and interference with mitochondrial DNA induced apoptosis in moxifloxacin environment.

  2024cites this paper
• Repositioning of Antibiotics in the Treatment of Viral Infections

  2024cites this paper
• Immunomodulatory Effects of Fluoroquinolones in Community-Acquired Pneumonia-Associated Acute Respiratory Distress Syndrome

  2024influential citation
• Fluoroquinolones upregulate insulin-like growth factor-binding protein 3, inhibit cell growth and insulin-like growth factor signaling.

  2024cites this paper
• Preparation of photo-crosslinked microalgae-carboxymethyl chitosan composite hydrogels for enhanced wound healing.

  2024cites this paper
• Overcoming Microbiome-Acquired Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• Exploring cytokine dynamics in tuberculosis: A comparative analysis of patients and controls with insights from three-week antituberculosis intervention

  2024cites this paper
• “Pleiotropic” Effects of Antibiotics: New Modulators in Human Diseases

  2024cites this paper
• Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery

  2024cites this paper
• Impact of Antibiotic Exposure Before Immune Checkpoint Inhibitor Treatment on Overall Survival in Older Adults With Cancer: A Population-Based Study

  2023cites this paper
• Combined radiation injury and its impacts on radiation countermeasures and biodosimetry

  2023cites this paper
• Crohn's disease of the vulva: A unique presentation with an unconventional treatment approach

  2023cites this paper
• The Assessment of Cytotoxicity, Apoptosis Inducing Activity and Molecular Docking of a new Ciprofloxacin Derivative in Human Leukemic Cells

  2023cites this paper
• EFFICACY OF TOPOISOMERASE INHIBITOR II (LEVOFLOXACIN) COMBINED WITH ALLIUM SATIVUM ON EXPERIMENTAL CEREBRAL TOXOPLASMOSIS INFECTED MICE

  2023cites this paper
• Impact of local drug delivery and natural agents as new target strategies against periodontitis: new challenges for personalized therapeutic approach

  2023cites this paper
• Postantibiotic leukocyte enhancement-mediated reduction of intracellular bacteria by macrophages

  2023cites this paper
• Immuno-modulatory Drugs: a Rapid Way to Combat the Tuberculosis

  2022cites this paper
• A Study on Repositioning Nalidixic Acid via Lanthanide Complexation: Synthesis, Characterization, Cytotoxicity and DNA/Protein Binding Studies

  2022influential citation
• Ocular microbiota promotes pathological angiogenesis and inflammation in sterile injury-driven corneal neovascularization

  2022cites this paper
• Pleiotropic effects of antibiotics on T cell metabolism and T cell-mediated immunity

  2022influential citation
• Therapeutic options for perifolliculitis capitis abscedens et suffodens: A review

  2022cites this paper
• Evaluation of the Effect of Ciprofloxacin on some Cytokines in Mice

  2022cites this paper
• Immune Parameters in Chickens Treated with Antibiotics and Probiotics during Early Life

  2022cites this paper
• Macrophage Secretory Function among Urinary Tract Infection Patients before and after Ciprofloxacin Treatment: A Prospective Study

  2022cites this paper
• Common themes in antimicrobial and anticancer drug resistance

  2022cites this paper
• Levofloxacin might be safe to use for OSCC patients

  2021cites this paper
• Antibiotics for secondary prevention of coronary heart disease.

  2021cites this paper
• Evaluation of immunomodulatory effects of lomefloxacin in mice

  2021cites this paper
• Repurposing Immunomodulatory Drugs to Combat Tuberculosis

  2021influential citation
• Biological Effects of Quinolones: A Family of Broad-Spectrum Antimicrobial Agents

  2021cites this paper
• Association of Sepsis Mortality with Specific Cancer Sites and Treatment Type: The Multiethnic Cohort Study

  2021cites this paper
• Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology

  2021influential citation
• Sitafloxacin reduces tumor necrosis factor alpha (TNFα) converting enzyme (TACE) phosphorylation and activity to inhibit TNFα release from lipopolysaccharide-stimulated THP-1 cells

  2021cites this paper
• Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever

  2021cites this paper
• Neuroinflammatory gene expression in chronic prostatitis/chronic pelvic pain syndrome patients: insights into etiology and phenotype biology

  2021cites this paper
• Chronic Prostatitis and Pelvic Pain Syndrome: Another Autoimmune Disease?

  2021cites this paper
• Treatment challenges and delivery systems in immunomodulation and probiotic therapies for periodontitis

  2021cites this paper
• Fluoroquinolones Suppress TGF-β and PMA-Induced MMP-9 Production in Cancer Cells: Implications in Repurposing Quinolone Antibiotics for Cancer Treatment

  2021influential citation
• Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease

  2021cites this paper
• Repurposing of antibiotics for clinical management of COVID-19: a narrative review

  2021cites this paper
• Antibacterial activity and action mode of Cu(I) and Cu(II) complexes with phosphines derived from fluoroquinolone against clinical and multidrug-resistant bacterial strains.

  2020cites this paper
• Nemonoxacin Has Immunoprotective Effects on Reducing Mortality in Lipopolysaccharide-Induced Mouse Sepsis Model

  2020cites this paper
• Daily Moxifloxacin, Clarithromycin, Minocycline, and Clofazimine in Nonresponsiveness Leprosy Cases to Recommended Treatment Regimen

  2020cites this paper
• High throughput screening assay to identify small molecule inhibitors of Marburg virus VP40 protein.

  2020cites this paper
• A Review of Immunomodulatory Effects of Fluoroquinolones

  2020cites this paper
• A comparative analysis of the efficacy of moxifloxacin and cefixime in reduction postoperative inflammatory sequelae after mandibular third molar surgery

  2020cites this paper
• Liver Sinusoidal Endothelial Cells Contribute to Hepatic Antigen-Presenting Cell Function and Th17 Expansion in Cirrhosis

  2020cites this paper
• Association of prior fluoroquinolone treatment with survival outcomes of immune checkpoint inhibitors in Asia

  2020cites this paper
• Antibiotics for cancer treatment: A double-edged sword

  2020cites this paper
• Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?

  2020cites this paper
• Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums

  2020cites this paper
• Rare-Earth Metal Complexes of the Antibacterial Drug Oxolinic Acid: Synthesis, Characterization, DNA/Protein Binding and Cytotoxicity Studies

  2020cites this paper
• Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness.

  2019cites this paper
• Evaluation and in vivo efficacy study of pyrano[3,2‐c]quinoline analogues as TNF‐α inhibitors

  2019cites this paper
• Immune-checkpoint inhibitors and the importance of concomitant medications: focus on antibiotics.

  2019cites this paper
• Sustained release of antimicrobials from double-layer nanofiber mats for local treatment of periodontal disease, evaluated using a new micro flow-through apparatus.

  2019cites this paper
• Effect of Combined &bgr;‐Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community‐Acquired Pneumonia

  2019cites this paper
• Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth.

  2019cites this paper
• Reproductive toxicity of fluoroquinolones in birds

  2019cites this paper
• Alternate Anti-Leprosy Regimen for Multidrug Therapy Refractory Leprosy: A Retrospective Study from a Tertiary Care Center in North India.

  2019cites this paper
• Drug Selection and Optimization of Dosage Schedules To Minimize Antimicrobial Resistance

  2019cites this paper
• Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway

  2019cites this paper
• Alhagi maurorum aqueous extract protects against norfloxacin-induced hepato-nephrotoxicity in rats

  2019cites this paper
• Norfloxacin, a Fluoroquinolone Antibiotic, Inhibits Langerhans Cell-Mediated Th1 and Th2 Cell Development.

  2019cites this paper
• Impact of different antimycotics on cytokine levels in an in vitro aspergillosis model in human whole blood

  2019cites this paper
• Sepsis and Risk of Cancer Among Elderly Adults in the United States

  2018cites this paper
• Role of gram‐positive bacteria in chronic pelvic pain syndrome (CPPS)

  2018cites this paper
• Link between rheumatoid arthritis and chronic periodontitis

  2018cites this paper
• Immunobiological efficacy and immunotoxicity of novel synthetically prepared fluoroquinolone ethyl 6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate.

  2018cites this paper
• Daptomycin.

  2018cites this paper
• Under ambient UVA exposure, pefloxacin exhibits both immunomodulatory and genotoxic effects via multiple mechanisms.

  2018cites this paper
• Chromosomal Disturbances during Mitotic Activity of Root Tip Cells in Allium by Certain Commonly Used Antibiotics

  2018cites this paper
• Ciprofloxacin Enhances TRAIL-Induced Apoptosis in Lung Cancer Cells by Upregulating the Expression and Protein Stability of Death Receptors through CHOP Expression

  2018cites this paper
• In vitro lung epithelial cell transport and anti‐interleukin‐8 releasing activity of liposomal ciprofloxacin

  2018cites this paper
• Chronic Urticaria and Monoclonal IgM Gammopathy

  2017cites this paper
• Antibiotic prophylaxis for infections in patients with acute stroke: a systematic review and meta-analysis of randomized controlled trials

  2017cites this paper
• Low-dose norfloxacin and ciprofloxacin therapy worsen leptospirosis in hamster.

  2017cites this paper
• Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice

  2017cites this paper
• The Synergistic Effects of the Combination of Ciprofloxacin and Temozolomide on Human Glioblastoma A-172 Cell Line

  2017cites this paper
• Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.

  2017cites this paper
• Evaluation of the Cytotoxic Effects of Ciprofloxacin on Human Glioblastoma A-172 Cell Line

  2017cites this paper
• Spectroscopic studies and thermal analysis of mononuclear metal complexes with moxifloxacin and 2,2′-bipyridine and their effects on acute lung injury induced by hydrochloric acid in rats

  2017cites this paper
• Interaction between Marbofloxacin and Flunixin in Treatment of Pneumonia in Lambs

  2017cites this paper
• Occurrence of veterinary pharmaceuticals in golden eagle nestlings: Unnoticed scavenging on livestock carcasses and other potential exposure routes.

  2017cites this paper
• Assessment of Immunomodulatory Activities and in vitro Toxicity of New Quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-h]quinoline-7-carboxylate

  2017influential citation
• Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial

  2017cites this paper
• Antibiotics for secondary prevention of coronary heart disease

  2017cites this paper